| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.64B | +2.8% |
| Cost of Revenue | $326.2M | -3.6% |
| Gross Profit | $1.31B | +4.5% |
| R&D Expense | $315.2M | -5.9% |
| SG&A Expense | $185.2M | +13.8% |
| Operating Income | $127.0M | +278.5% |
| Income Tax | $43.2M | -10.1% |
| Net Income | $9.9M | +107.9% |
| EPS (Basic) | $0.03 | +107.0% |
| EPS (Diluted) | $0.03 | +107.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $912.5M | +24.6% |
| Short-term Investments | $320.0M | +23.1% |
| Accounts Receivable | $509.8M | +2.0% |
| Current Assets | $1.99B | +13.4% |
| Total Assets | $5.28B | +1.5% |
| Current Liabilities | $1.09B | +3.5% |
| Long-term Debt | $1.79B | -1.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $409.9M | +53.9% |
| Capital Expenditures | $3.9M | -39.7% |
| Investing Cash Flow | -$70.7M | -26.6% |
| Financing Cash Flow | -$146.2M | -784.3% |
| Free Cash Flow | $405.9M | +56.2% |
| Total Liabilities |
| $2.97B |
| -0.6% |
| Stockholders' Equity | $2.31B | +4.3% |